Please sign in to follow a disease.
Could a tiny jolt to the head diagnose balance problems?
NCT ID NCT07267910
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 3 times
Summary
This early study will test whether weak electrical currents applied to the head can help diagnose balance disorders like vestibular schwannoma and vestibular neuritis. Researchers will measure how 30 people with these conditions sway or move in response to the stimulation. The goal is to see if this simple, non-invasive method can reliably detect inner-ear problems and possibly guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- weak alternating-current electrical stimulation (device)
- What this could lead to
- If successful, this could provide a new, non-invasive way to diagnose balance disorders and possibly guide rehabilitation.
- What could go wrong
- This is a very early, small study (30 people) that only tests the method's feasibility. It may not lead to a reliable diagnostic tool or any treatment benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Signed informed consent form * One of the following: clinically diagnosed vestibular schwannoma, vestibular neuritis, or simultaneous unilateral hearing loss and vestibular dysfunction. Exclusion Criteria: * History of epilepsy or seizures * Past brain surgery * Pacemaker, cochlear implant, or other implanted medical device * Pregnancy * Skin problems or damaged skin at the site of the stimulation (scalp and neck)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Unilateral hearing loss and vestibular dysfunction are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Dept. of Otorhinolaryngology, HUS Helsinki University Hospital
Helsinki, 00130, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Inner ear clues to childhood balance problems put to the test
- Hearing loss in children may hide a balance problem, and doctors are testing for it
- Can a precise radiation beam spare balance? a study investigates
- Could a symptom registry unmask hidden migraine variants?
- Smart sensors could predict falls in older adults with dizziness
- New platform trial takes on NF2 tumors with multiple drug strategies